Darunavir ethanolate

This classification denotes a protease inhibitor C27H37N3O7S.C2H6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33O78XF0BW, chemically known as ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)- carbamic acid (3r,3as,6ar)-hexahydrofuro(2,3-b)furan-3-yl ester monoethanolate, but more generally known as darunavir ethanolate, which bears US NIH Compound Identifier 23725083. European Medicines Agency schedules Darunavir ethanolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23573. Most nations, for tariff and trade purposes, schedule darunavir ethanolate under HS 29350090 and SITC 51580. As of Q4 2014, DARUNAVIR ETHANOLATE remains US FDA's Preferred Term for this commodity. Darunavir ethanolate bears US NLM identifiers UMLS ID C1725651 and NCI Concept Code C77389. SMILES: CCO.CC(C)CN(C[C@H]([C@H](CC1CCCCC1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4CCC(CC4)N.